Study guide

10.1 PALICC-2 Diagnosis & Severity

NBRC RRT-NPS Neonatal/Pediatric Specialist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Neonatal and Pediatric Patient Assessment

1.1 Maternal, Obstetric & Perinatal History 1.2 Fetal Surveillance & Antepartum Diagnostics 1.3 Gestational Age & Baseline Neonatal Examination 1.4 Apgar, Respiratory Distress & Thoracic Assessment 1.5 Pediatric Assessment Triangle & Vital Signs 1.6 Neurologic Assessment, Respiratory Failure & Triage

2 Chapter 2: Diagnostic Evaluation & Gas Exchange Monitoring

2.1 Pulse Oximetry, Pre/Postductal & Transcutaneous Monitoring 2.2 Capnography, Waveforms & Dead-Space Evaluation 2.3 Arterial & Capillary Blood-Gas Sampling 2.4 Umbilical Lines, Acid-Base & Laboratory Evaluation 2.5 Chest Imaging & Airway Radiography 2.6 Pulmonary Function, Bronchoscopy & Specimen Diagnostics

3 Chapter 3: Airway Management & Secretion Clearance

3.1 Pediatric Airway Anatomy & ETT Sizing 3.2 Cuffed Airways, Intubation & Difficult-Airway Management 3.3 Tracheostomy Devices & Routine Care 3.4 Tracheostomy Emergencies, Speaking & Decannulation 3.5 Airway Suctioning Technique & Safety 3.6 Airway Clearance, Home Care & Discharge Planning

4 Chapter 4: Pharmacology & Medical Gas Therapy

4.1 Aerosol Physics & Delivery Devices 4.2 Respiratory & Systemic Pharmacology 4.3 Oxygen Interfaces & Delivery Systems 4.4 Oxygen Blenders, Targets & Toxicity 4.5 HFNC Physiology, Sizing & Flow 4.6 HFNC Indications, Monitoring & Escalation

5 Chapter 5: Shared Neonatal & Pediatric Pulmonary Disorders

5.1 Neonatal RDS Pathophysiology & Management 5.2 TTN, Pneumonia & the Neonatal Differential 5.3 Meconium Aspiration & PPHN 5.4 BPD, Apnea & Chronic Neonatal Lung Disease 5.5 Bronchiolitis, Croup & Epiglottitis 5.6 Asthma, Cystic Fibrosis & Foreign-Body Aspiration

6 Chapter 6: Resuscitation, Emergency Protocols & Patient Safety

6.1 NRP Cord Management, Initial Steps & Ventilation 6.2 NRP Corrective Steps, Compressions & Medications 6.3 PALS Assessment, CPR & Cardiac Arrest 6.4 PALS Dysrhythmia & Shock Management 6.5 Neonatal & Pediatric Transport 6.6 Patient Safety, Teamwork & Family-Centered Care

7 Chapter 7: Noninvasive & Conventional Mechanical Ventilation

7.1 Bubble CPAP & Neonatal NIV 7.2 Pediatric NIV, Interfaces & Failure Recognition 7.3 Conventional Ventilation Physics & Modes 7.4 Initial Settings & ABG-Guided Titration 7.5 Ventilator Scalars & Loops 7.6 Ventilator Dyssynchrony & Troubleshooting 7.7 Weaning Readiness & Spontaneous Breathing Trials 7.8 Extubation & Post-Extubation Airway Risk

8 Chapter 8: High-Frequency Ventilation & Advanced Modes

8.1 HFOV Mechanics & Gas Transport 8.2 HFOV Controls & Clinical Management 8.3 HFJV Circuit & Controls 8.4 HFJV Servo Pressure & Clinical Indications 8.5 NAVA, Edi & Proportional Support 8.6 APRV in Pediatric Respiratory Failure

9 Chapter 9: Specialty Inhaled Gases & Exogenous Surfactant Therapy

9.1 Inhaled Nitric Oxide: Mechanism, Indications & Dose 9.2 Inhaled Nitric Oxide: Toxicity, Monitoring & Weaning 9.3 Heliox Physics & Delivery 9.4 Volatile Anesthetic & Subambient Gas Therapy 9.5 Surfactant Biology, Products & Dosing 9.6 Surfactant Administration & Response

10 Chapter 10: Pediatric ARDS & Parenchymal Critical Illness

10.1 PALICC-2 Diagnosis & Severity 10.2 PALICC-2 NIV & Possible PARDS 10.3 PARDS Lung-Protective Ventilation 10.4 PARDS Refractory Hypoxemia & Adjuncts 10.5 PIE & Pneumothorax Recognition 10.6 Thoracic Decompression & Chest Drains

11 Chapter 11: Congenital Heart Disease & Hemodynamic Management

11.1 Left-to-Right Shunts & Qp/Qs Physiology 11.2 Acyanotic Lesions & Respiratory Management 11.3 Cyanotic Lesions & the Five Ts 11.4 Ductal Dependence, PGE1 & the Hyperoxia Test 11.5 Single-Ventricle Physiology & Staged Palliation 11.6 Gas Balancing, Hemodynamics & NIRS

12 Chapter 12: Advanced Critical Care: ECMO, Neurotrauma & Palliative Care

12.1 ECMO Candidacy & Modality 12.2 ECMO Circuit, Lung Rest & Anticoagulation 12.3 Neurotrauma, ICP & Ventilation 12.4 Neonatal Therapeutic Hypothermia & Respiratory Care 12.5 Death by Neurologic Criteria: Examination & Apnea Testing 12.6 DNC Timing, Ancillary Testing, Palliation & Donation

10.1 PALICC-2 Diagnosis & Severity

Key Takeaways Explain This Topic AI

Invasive PALICC-2 disease is mild/moderate at OI 4 to less than 16 or OSI 5 to less than 12 and severe at OI at least 16 or OSI at least 12.

Assess severity at least four hours after diagnosis and use OI or OSI rather than P/F or S/F for invasive ventilation.

New unilateral or bilateral parenchymal opacities qualify when edema is not fully explained by cardiac failure or fluid overload.

Last updated: September 2026

10.1 PALICC-2 Diagnosis & Severity

PALICC-2 uses pediatric physiology and available monitoring rather than importing the adult Berlin definition. Apply the definition to patients younger than 18 years without active perinatal lung disease, then reassess severity after initial stabilization. Identify and treat the precipitating insult while ruling out hydrostatic edema as the main explanation.

Diagnostic Framework

PARDS begins within seven days of a known clinical insult. Chest imaging shows new unilateral or bilateral opacities consistent with acute pulmonary parenchymal disease; atelectasis or pleural effusion alone does not satisfy the imaging element. Respiratory failure must not be fully explained by cardiac failure or fluid overload, although cardiac disease can coexist. Echocardiography and hemodynamic assessment help when the origin of edema is uncertain.

For an invasively ventilated patient, OI or OSI is preferred:

  • OI = (mean airway pressure x FiO2 x 100) / PaO2
  • OSI = (mean airway pressure x FiO2 x 100) / SpO2

Use OSI only when saturation is in a range where it can track changes in oxygenation; obtain arterial oxygen tension when the classification or treatment decision requires it.

Invasive PARDS Thresholds

An invasively ventilated patient meets the oxygenation criterion at OI 4 or higher or OSI 5 or higher. Grade severity at least four hours after the initial diagnosis so the result reflects response to stabilization rather than one transient value.

  • Invasive category Oxygenation index Oxygen saturation index
  • Mild/moderate PARDS OI 4 to less than 16 OSI 5 to less than 12
  • Severe PARDS OI 16 or higher OSI 12 or higher

PALICC-2 does not divide invasive disease into separate mild OI 4-8 and moderate OI 8-16 bands. A computed OI of 16.1 is severe. Record the inputs and verify that FiO2 is entered as a decimal; multiplying by 100 is already part of the equation.

Calculation Discipline and Reclassification

Compute OI from measurements obtained close together. If MAP is 14 cm H2O, FiO2 is 0.60, and PaO2 is 70 mmHg, OI is (14 x 0.60 x 100) / 70 = 12, which is mild/moderate invasive PARDS. If PaO2 falls to 50 with the other inputs unchanged, OI becomes 16.8 and meets severe criteria. That change should prompt confirmation of tube position, circuit function, hemodynamics, secretion burden, pneumothorax, and disease progression before attributing it only to PARDS.

OSI is most useful when arterial sampling is unavailable and the saturation signal is reliable. Dyshemoglobinemia, motion, poor perfusion, a weak plethysmographic waveform, or saturation on the flat upper portion of the oxyhemoglobin curve can distort interpretation. Do not mix PaO2 from one time with MAP and FiO2 from another.

Differential diagnosis

Cardiogenic edema, fluid overload, diffuse atelectasis, pleural disease, pulmonary hemorrhage, and chronic lung disease can resemble PARDS. PALICC-2 allows cardiac dysfunction to coexist, but acute lung disease must not be fully explained by the heart or volume status. Use echocardiography, fluid balance, examination, imaging, and response to therapy together.

Timing Example

A child may meet PARDS criteria at noon yet have an OI inflated by a brief derecruitment event. Stabilize the airway, ventilator, PEEP, and circulation, then assign severity after at least four hours. Record whether the score represents the worst value or a protocol-specified assessment. A later improvement from OI 18 to 11 changes the severity band but does not erase the diagnosis; continue trending and treating the underlying pneumonia, sepsis, aspiration, trauma, or other insult.

Cyanotic heart disease

Children with cyanotic congenital heart disease can still develop PARDS. Compare current oxygenation with the patient's baseline and determine whether the acute deterioration is explained by the cardiac lesion alone. OI, OSI, P/F, and S/F may be difficult to interpret at low baseline saturations, so combine the trend with imaging, ventricular and shunt assessment, perfusion, and the precipitating insult. The diagnosis requires an acute pulmonary process beyond the expected cardiac physiology.

When a value sits at a category boundary, repeat the measurement after checking signal quality, arterial sampling, ventilator data, and patient stability. Classification is a communication tool; it never replaces urgent treatment of a displaced tube, tension pneumothorax, shock, or another immediately reversible emergency.

Reassessment Rule

Record which oxygenation metric was used, when it was measured, and whether signal quality and airway pressure were reliable. Reclassify after stabilization; an improving or worsening trend can matter more than a single boundary value.